ArticleCell death & disease2022

Targeting TPC2 sensitizes acute lymphoblastic leukemia cells to chemotherapeutics by impairing lysosomal function.

Franz Geisslinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.